Raptakind Pharmaceuticals Private Limited
About Raptakind Pharmaceuticals Private Limited
Data last updated:
Raptakind Pharmaceuticals Private Limited is a private limited company based in Muzaffarpur, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 20 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U51909BR2012PTC019675. Its GSTIN is 10AAGCR2307A1ZC (Bihar).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ranjeet Kumar Singh (Managing Director) and Ranjeeta Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Muzaffarpur, Bihar.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.9 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹12,695 (net margin 0.9%) and EBITDA of ₹85,791 (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 23% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹5.1 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Raptakind Pharmaceuticals Private Limited's registered office is in Muzaffarpur, Bihar. Its e-mail address is in the company report.
- Email
- Registered AddressSushila Sadan H. No. – 229 Main Road Sahjanand Colony Rewa Road B, Hagwanpur, Muzaffarpur, Bihar, India – 842001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Raptakind Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Raptakind Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Raptakind Pharmaceuticals Private Limited, buy the company report.
Financials of Raptakind Pharmaceuticals Private Limited
FY 2025 filings availableRaptakind Pharmaceuticals Private Limited reported revenue of ₹14.9 Lakh (up 17% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 17% growth in the latest year. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,791 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12,695 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Raptakind Pharmaceuticals Private Limited, buy the company report.
Board of directors of Raptakind Pharmaceuticals Private Limited
Raptakind Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjeet Kumar Singh | Managing Director | 20 Dec 2012 | 13 Years 10 Months | Current |
| Ranjeeta Kumari | Director | 01 Feb 2017 | 9 Years 9 Months | Current |
Peer comparison
Raptakind Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biomash Pharmaceuticals Private Limited | ₹14.98 Lakh (FY 2024) | -25.0% | Jaipur, Rajasthan, India | |||
| Es Laetus Pharmaceuticals Private Limited | ₹14.95 Lakh (FY 2025) | -4.0% | Kannur, Kerala, India | |||
| Raptakind Pharmaceuticals Private Limitedthis company | ₹14.9 Lakh (FY 2024) | ₹12,695 | 0.9% | 17.0% | Muzaffarpur, Bihar, India | |
| Dermace Pharmaceuticals Private Limited | ₹14.86 Lakh (FY 2025) | -32.0% | Sikandarpur, Uttar Pradesh, India | |||
| Fyzomax Pharmaceuticals Private Limited | ₹14.85 Lakh (FY 2025) | -6.0% | Delhi, India | |||
| N.E. Pharmaceuticals Private Limited | ₹14.85 Lakh (FY 2019) | Guwahati, Assam, India |
To see the full peer comparison of Raptakind Pharmaceuticals Private Limited, buy the company report.
Auditor
Raptakind Pharmaceuticals Private Limited is audited by ABHISHEKKUMAR for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ABHISHEKKUMAR | FY 2017 | 524988 |
Shareholding
The shareholding of Raptakind Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Raptakind Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Nov 2020 | 100413580 | Hdfc Bank Limited | ₹5.1 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raptakind Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raptakind Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raptakind Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCR2307A1ZC | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Raptakind Pharmaceuticals Private Limited, buy the company report.
Recent activity
Raptakind Pharmaceuticals Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Rajeev Kumar ceased to be Director on 01 Feb 2017.
Frequently asked questions
Raptakind Pharmaceuticals is an active private limited company based in Muzaffarpur, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 20 December 2012 (14+ years old) and is registered under CIN U51909BR2012PTC019675.
Raptakind Pharmaceuticals has 2 current directors:
- Ranjeet Kumar Singh - Managing Director
- Ranjeeta Kumari - Director
The latest financial statements of Raptakind Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Raptakind Pharmaceuticals is 10AAGCR2307A1ZC, registered in Bihar.
The CIN (Corporate Identification Number) of Raptakind Pharmaceuticals is U51909BR2012PTC019675. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raptakind Pharmaceuticals was incorporated on 20 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Raptakind Pharmaceuticals by revenue are Biomash Pharmaceuticals Private Limited, Es Laetus Pharmaceuticals Private Limited, Dermace Pharmaceuticals Private Limited, Fyzomax Pharmaceuticals Private Limited, N.E. Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rajeev Kumar ceased to be Director on 01 Feb 2017. Ranjeeta Kumari was appointed as Director on 01 Feb 2017. Ranjeet Kumar Singh was appointed as Managing Director on 20 Dec 2012.
The registered office of Raptakind Pharmaceuticals is at Sushila Sadan H. No. – 229 Main Road Sahjanand Colony Rewa Road B, Hagwanpur, Muzaffarpur, Bihar, India – 842001.
Raptakind Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Raptakind Pharmaceuticals has open charges of ₹5.1 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
